Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
September 30, 2026 -12.79M
June 30, 2026 1.548M
March 31, 2026 -15.60M
December 31, 2025 -16.66M
September 30, 2025 -11.07M
June 30, 2025 -22.79M
March 31, 2025 -12.31M
September 30, 2024 -24.95M
June 30, 2024 -5.298M
Date Value
March 31, 2024 -9.143M
December 31, 2023 -14.25M
September 30, 2023 -5.474M
June 30, 2023 -18.89M
March 31, 2023 -9.107M
December 31, 2022 -15.71M
September 30, 2022 -11.05M
June 30, 2022 -10.37M
March 31, 2022 -19.28M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc -2.037M
Mereo BioPharma Group Plc -4.048M
Compass Pathways Plc -50.74M
HemoGenyx Pharmaceuticals Plc --